Differential Impact of Statin on New-Onset Diabetes in Different Age Groups: A Population-Based Case-Control Study in Women from an Asian Country | PLOS ONE
Statins in Diabetes Treatment: Risks and Benefits - GoodRx
Statine: Risikofaktor für Diabetes Typ 2 | APOTHEKE ADHOC
Hypertriglyceridemia affects nearly 20% of adults with diabetes despite statin use
Simvastatin Protects against Multiple Low-Dose Streptozotocin-Induced Type 1 Diabetes in CD-1 Mice and Recurrence of Disease in Nonobese Diabetic Mice | Journal of Pharmacology and Experimental Therapeutics
Simvastatin Improves Diabetes-Induced Coronary Endothelial Dysfunction | Journal of Pharmacology and Experimental Therapeutics
Statins linked to diabetes risk
Risk of incident diabetes among patients treated with statins: population based study | The BMJ
The People's Pharmacy
Study identifies best statins for reducing cardiovascular risk in people with diabetes - Keele University
Statin Use in Persons with Diabetes (SUPD)
Statins increase the risk of developing diabetes in at-risk people
Best statins for reducing cardiovascular risk in people with diabetes found
Statin-Related New-Onset Diabetes Appears Driven by Increased Insulin Resistance: Are There Clinical Implications? | Arteriosclerosis, Thrombosis, and Vascular Biology
Risk and Benefits of Statins in Glucose Control Management of Type II Diabetes | Semantic Scholar
PDF) Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses | Alberico Catapano and N. Abate -
PDF) The Effect of Simvastatin on Glucose Homeostasis in Streptozotocin Induced Type 2 Diabetic Rats
FDA Warns Statin Users of Diabetes Risk | TIME.com
Statins and diabetes
Statins side effects - drugs could increase risk of type 2 diabetes | Express.co.uk
RACGP - Statins may increase risk of developing type 2 diabetes: New study
Benarkah Obat Statin Meningkatkan Risiko Diabetes? Halaman all - Kompas.com
Simvastatin mitigates streptozotocin-induced type 1 diabetes in mice through downregulation of ADAM10 and ADAM17 - ScienceDirect
